Applied DNA Sciences Inc

詳細情報 Applied DNA Sciences Inc 企業名

Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.

企業情報

企業コードAPDN

会社名Applied DNA Sciences Inc

上場日Aug 24, 2001

最高経営責任者「CEO」Ms. Judith Murrah

従業員数46

証券種類Ordinary Share

決算期末Aug 24

本社所在地50 Health Sciences Drive

都市STONY BROOK

証券取引所NASDAQ Capital Market Consolidated

国United States of America

郵便番号11790

電話番号16312408800

ウェブサイトhttps://adnas.com/

企業コードAPDN

上場日Aug 24, 2001

最高経営責任者「CEO」Ms. Judith Murrah

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Clay Shorrock, J.D.

President of LRx

4.00

--

Ms. Beth M. Jantzen

Chief Financial Officer

3.00

--

Ms. Judith Murrah

Chairman of the Board, President, Chief Executive Officer

3.00

--

Mr. Robert B. (Bob) Catell

Independent Director

2.00

--

Dr. Yacov A. Shamash, Ph.D.

Independent Director

2.00

--

Mr. Joseph D. Ceccoli

Independent Director

1.00

--

Ms. Elizabeth M. Schmalz Shaheen

Independent Director

--

Mr. Sanford (Sandy) Simon

Independent Director

--

Mr. Sanjay M. Hurry

Executive Director - Investor Relations and Corporate Communications

--

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Clay Shorrock, J.D.

President of LRx

4.00

--

Ms. Beth M. Jantzen

Chief Financial Officer

3.00

--

Ms. Judith Murrah

Chairman of the Board, President, Chief Executive Officer

3.00

--

Mr. Robert B. (Bob) Catell

Independent Director

2.00

--

Dr. Yacov A. Shamash, Ph.D.

Independent Director

2.00

--

Mr. Joseph D. Ceccoli

Independent Director

1.00

--

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Product and authentication services - Large scale DNA production

333.66K

33.93%

Product and authentication services - Supply chain

290.23K

29.51%

Clinical laboratory testing services (over-time)

220.55K

22.43%

Research and development services

133.55K

13.58%

Product and authentication services - Asset marking

5.38K

0.55%

データなし

事業別

地域別

事業別USD

会社名

収益

比率

Product and authentication services - Large scale DNA production

333.66K

33.93%

Product and authentication services - Supply chain

290.23K

29.51%

Clinical laboratory testing services (over-time)

220.55K

22.43%

Research and development services

133.55K

13.58%

Product and authentication services - Asset marking

5.38K

0.55%

株主

更新時刻: Fri, Sep 19

株主統計

種類

株主統計

比率

Anson Funds Management LP.

3.60%

Sabby Management, LLC

1.89%

UBS Financial Services, Inc.

0.86%

Altium Capital Management LP

0.50%

S.H.N. Financial Investments Ltd

0.39%

他の

92.76%

株主統計

比率

Anson Funds Management LP.

3.60%

Sabby Management, LLC

1.89%

UBS Financial Services, Inc.

0.86%

Altium Capital Management LP

0.50%

S.H.N. Financial Investments Ltd

0.39%

他の

92.76%

種類

株主統計

比率

Hedge Fund

3.62%

Investment Advisor/Hedge Fund

2.39%

Investment Advisor

0.86%

Corporation

0.71%

Individual Investor

0.40%

Bank and Trust

0.04%

Research Firm

0.01%

他の

91.97%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

62

34.98K

6.73%

-8.84K

2025Q1

84

45.20K

34.86%

+11.50K

2024Q4

79

25.60M

46.39%

+1.44M

2024Q3

74

1.08M

9.78%

+703.30K

2024Q2

73

1.19M

10.83%

+424.27K

2024Q1

67

243.32K

209.10%

+86.27K

2023Q4

64

96.98K

13.46%

-84.74K

2023Q3

66

149.12K

21.28%

-82.31K

2023Q2

68

142.47K

21.43%

-74.27K

2023Q1

68

128.77K

20.06%

-84.88K

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Anson Funds Management LP.

4.57K

0.88%

-9.44K

-67.39%

Apr 03, 2025

Sabby Management, LLC

6.97K

1.34%

+1.29K

+22.64%

Dec 31, 2024

UBS Financial Services, Inc.

2.31K

0.44%

+2.31K

--

Mar 31, 2025

Altium Capital Management LP

6.50K

1.25%

--

Apr 03, 2025

S.H.N. Financial Investments Ltd

5.03K

0.97%

--

Apr 03, 2025

Bigger (Michael)

5.00K

0.96%

--

Apr 03, 2025

L1 Capital Global Opportunities Master Fund Ltd.

4.17K

0.8%

--

Apr 03, 2025

Tower Research Capital LLC

32.00

0.01%

+18.00

+128.57%

Mar 31, 2025

SBI Securities Co., Ltd.

67.00

0.01%

-90.00

-57.32%

Mar 31, 2025

詳細を見る

2.940USD

Applied DNA Sciences Inc

2.940

概要

企業名

金融

分析